Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events what matters most alzheimer’s treatment research
… Pooled Data Analysis of Long-Term Treatment Effect OPPORTUNITY Our client had a treatment for kidney disease that had been shown to slow … short-term clinical studies. They wanted to assess their treatment compared with standard of care on the annual rate …
… in solving problems and helping people, so that is what made RTI-HS a great place for me after finishing my master’s program in industrial engineering. I feel fortunate to have … and opportunities to learn and improve on my skillset. Most recently, I felt ready to expand my programming …
… 30 Years of ISOQOL: Quality of Life – making it relevant. Research and presentations by RTI Health Solutions experts … correlations among ordinal measures. Rockwood N, Qin S, Yarr S. Session: Oral Brief Session 202: Methodological … for successful in-trial interviews: the who, what, when, where, and how. DiBenedetti D, Doward L. …
… Understanding Treatment Trends for Chronic Lymphocytic Leukemia Time trends … lymphocytic leukemia in the United States Goyal R, Nagar S, Davis KL, Kaye JA Transcript: Targeted treatments have … period. In contrast, the use of a first-in-class Bruton’s tyrosine kinase inhibitor, ibrutinib, increased sharply to …
… Watch the Recording Demonstrate Your Therapeutic Product's Value You need a global value dossier (GVD) that … the value of your new pharma or medical device product. What unmet needs does it address? Your research findings and value must be clearly articulated, …
… and other decision-makers perceive the benefits of your treatment features and their tolerance for possible risks. Given available treatment choices, patients may be willing to accept certain … relative importance of benefits and risks and a patient’s maximum acceptable risk (MAR). If the actual risk exposure …
… FDA’s Sentinel Initiative Driving Sound Research Practices for COVID-19 Vaccine Development Share … Perspectives. The session focused on the BEST System’s work with partners to support COVID-19 pandemic efforts – …
… the development of new therapies—we are passionate about what we do. Our scientists actively participate in industry …
… EMA Selects Research Collaboration to Prepare for Rapid Assessment Of … the European Medicines Agency (EMA) has commissioned research to monitor any vaccine that is approved for its … case series analyses of specific severe adverse events as well as for monitoring the effectiveness of …
… decision-makers need to decide which products will be most beneficial to patients and cost-effective for health … information exchange (PIE), and real-world evidence (RWE). What additional best practices are recommended in version 5.0 … focused materials to help communicate a product’s key clinical and economic evidence to healthcare …